You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Details for Patent: 10,010,517


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,010,517 protect, and when does it expire?

Patent 10,010,517 protects VASCEPA and is included in one NDA.

This patent has fifty-one patent family members in twenty-seven countries.

Summary for Patent: 10,010,517
Title:Stable pharmaceutical composition and methods of using same
Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
Inventor(s): Manku; Mehar (Birmingham, GB), Osterloh; Ian (Kent, GB), Wicker; Pierre (Mystic, CT), Braeckman; Rene (Richboro, PA), Soni; Paresh (Mystic, CT)
Assignee: AMARIN PHARMACEUTICALS IRELAND LIMITED (Dublin, IE)
Application Number:15/415,468
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,010,517

Introduction

When analyzing a U.S. patent, it is crucial to understand the various components that define its scope and claims. This article will delve into the specifics of United States Patent 10,010,517, using it as a case study to explain the key elements of a patent, including the drawings, specification, claims, and other relevant sections.

Patent Structure Overview

A U.S. patent is structured into several key sections, each serving a distinct purpose.

Drawings

The drawings section contains black and white illustrations that detail the technical aspects of the invention. These drawings are essential for visualizing the invention and are often required, although exceptions exist for process or method inventions[1].

Specification

The specification is a written description of the invention, including discussions of prior art, descriptions of the drawings, the technical problem the invention solves, and the preferred embodiment of the invention. This section must provide enough detail so that anyone with ordinary skill in the same technical field can understand and replicate the invention[1].

Claims

The claims section defines the scope of protection for the patent. Claims are paragraphs at the end of the specification that start with phrases like “I claim” or “What is claimed.” These claims outline the legal boundaries of the invention, similar to how a property deed defines physical boundaries. A patent must have at least one claim, but it can have several or even hundreds[1].

Analyzing the Claims of United States Patent 10,010,517

Claim Structure

To understand the claims of a patent like 10,010,517, one must look at the independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details.

Strategic Claim Management

The number and composition of claims are critical. The initial patent application filing fee in the U.S. covers up to 3 independent claims and a total of 20 claims. However, the strategic management of these claims can significantly enhance the patent’s effectiveness and value. For example, consolidating multiple dependent claims into fewer, broader independent claims can facilitate application approval and maximize the patent’s breadth and flexibility without additional costs[2].

Claim Metrics

Metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Other Key Sections of the Patent

Abstract

The abstract provides a brief, non-technical description of the invention. It is limited to 500 characters or less and serves as a summary of the patent[1].

Field of Search

This section lists the classifications consulted by the patent examiner during the prior art search. It helps in understanding the broader context and related technologies[1].

References

The references section cites U.S. and foreign patent documents and other publications related to the invention. These citations are provided by both the inventor and the patent examiner to establish prior art[1].

Applicant and Inventors

The applicant is the person, company, or organization that filed the patent application. The inventors are listed separately, and the assignee is the owner of the patent at the time it was issued[1].

Patent Landscape and Search Tools

Patent Public Search

The USPTO offers various tools for searching patents, including the Patent Public Search tool, which replaced legacy search tools like PubEast and PubWest. This tool provides enhanced access to prior art and improves the overall patent searching process[4].

Global Dossier

The Global Dossier service allows users to access file histories of related applications from participating IP Offices. This service is useful for seeing the patent family for a specific application and accessing dossier, classification, and citation data[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This helps in visualizing search results for the same invention produced by several offices on a single page[4].

Maximizing Patent Value

Strategic Approach to Claims

A nuanced approach to claim management is crucial for maximizing patent value. Adding new dependent claims for every canceled claim ensures that the patent utilizes its full quota of claims, enhancing its breadth and flexibility without additional costs[2].

Impact on Patent Prosecution

Strategic claim management can streamline the patent prosecution process and ensure that clients receive maximum value for their investments. This approach demonstrates meticulous and value-driven management of intellectual property, which is essential in a competitive landscape[2].

Key Takeaways

  • Understanding Patent Structure: A patent includes drawings, specification, claims, abstract, field of search, and references.
  • Claims Management: Strategic management of claims is vital for maximizing patent value and ensuring comprehensive protection.
  • Patent Search Tools: Utilizing tools like Patent Public Search, Global Dossier, and CCD can enhance the patent searching process.
  • Metrics for Patent Scope: Independent claim length and count can be used to measure patent scope and predict the likelihood of grant and examination duration.

FAQs

What is the purpose of the drawings section in a U.S. patent?

The drawings section contains illustrations that detail the technical aspects of the invention, helping to visualize and understand it.

How many claims can be included in the initial patent application filing fee in the U.S.?

The initial patent application filing fee covers up to 3 independent claims and a total of 20 claims.

What metrics can be used to measure patent scope?

Independent claim length and independent claim count are simple metrics used to measure patent scope and have explanatory power for several correlates of patent scope.

What is the Global Dossier service?

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, providing a single portal for dossier, classification, and citation data.

Why is strategic claim management important?

Strategic claim management can streamline the patent prosecution process, ensure maximum value for clients, and enhance the patent’s defensive capabilities and commercial value.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. Harrityllp.com: Maximizing Patent Value: A Strategic Approach to Claim Management.
  3. SSRN.com: Patent Claims and Patent Scope.
  4. USPTO.gov: Search for patents - USPTO.
  5. ACUS.gov: U.S. Patent Small Claims Court.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,010,517

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 AB RX Yes Yes 10,010,517 ⤷  Try for Free USE OF VASCEPA TO LOWER TRIGLYCERIDES IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE (TG) LEVELS (ABOUT 200 MG/DL TO LESS THAN ABOUT 500 MG/DL) AND ON STATIN THERAPY ⤷  Try for Free
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 AB RX Yes No 10,010,517 ⤷  Try for Free USE OF VASCEPA TO LOWER TRIGLYCERIDES IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE (TG) LEVELS (ABOUT 200 MG/DL TO LESS THAN ABOUT 500 MG/DL) AND ON STATIN THERAPY ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,010,517

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010241571 ⤷  Try for Free
Brazil PI1011876 ⤷  Try for Free
Canada 2759284 ⤷  Try for Free
China 102458109 ⤷  Try for Free
China 104856985 ⤷  Try for Free
Colombia 6470838 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.